SCS/SB 942 - This act provides that pharmacists may label prescription drugs using either a sequential number or a unique identifier.
This provision is identical to provisions contained in HCS/HB 2131 (2014), HB 2285 (2014), HCS/SB 528 (2014), HCS/HB 717 (2014), and the truly agreed to and finally passed versions of SB 754 (2014) and SB 808 (2014).
The act states that the Board of Pharmacy may inspect Class B hospital pharmacies that are not under the inspection authority of the Department of Health and Senior Services. The Board and the Department of Health and Senior Services may jointly promulgate rules governing medication services by a pharmacist at or within a hospital. A drug distributor license is not required to transfer medication from a Class B hospital pharmacy to a hospital clinic for patient care. Medication dispensed by a hospital to a patient for use outside of the hospital shall be labeled as provided by rules jointly promulgated by the Department and the Board, and shall be dispensed only by a prescription order from a physician.
All pharmacists providing medication therapy services must obtain a certificate of medication therapeutic plan authority as provided by rule.
There shall be an advisory committee, with members appointed by the Board, which will make recommendations to the Board and review all rules jointly promulgated by the Board and the Department.
The act defines a "Class B Hospital Pharmacy," and provides that any hospital that holds a pharmacy license on the effective date of the act shall be eligible to obtain a Class B pharmacy license without the payment of a fee.
These provisions are substantially similar to provisions contained in HCS/SB 528 (2014), HB 2285 (2014), HCS/SB 717 (2014), and HCS/HB 2131 (2014), and to the truly agreed to and finally passed versions of SB 754 (2014) and SB 808 (2014).